Day: September 23, 2025
Ad hoc announcement pursuant to Art. 53 LR
A conference call will be held on September 23, 2025, at 14:00 CEST / 13:00 BST / 08:00 BST. Details are at the end of this news release
Pratteln, Switzerland, September 23, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the Company’s financial results for the six months ended June 30, 2025, reports on progress with AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) and provides updates on its corporate and financing initiatives.
HighlightsTotal revenue increased 70% to CHF 24 million (H1 2024: CHF 14.1 million) driven by strong sales growth in launched markets in addition to growing royalty and product supply revenues
Product sales increased 76% to CHF 11.6 million (H1 2024: CHF 6.6 million), led by Germany and Austria with first contributions from the UK following...
China Medical System (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies
Written by Customer Service on . Posted in Public Companies.
SHENZHEN, CHINA, Sept. 23, 2025 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 22 September 2025, the Group through its subsidiaries entered into two separate exclusive Collaboration Agreements (the “Agreements”) with Chongqing Genrix Biopharmaceutical Co., Ltd. (“Genrix Bio”) for two Class 1 therapeutic biological products, Vecantoxatug Injection (GR2001, “Vecantoxatug”) indicated for passive immunization against tetanus and Silevimig Injection (GR1801, “Silevimig”) indicated for passive immunization following suspected rabies virus exposure, respectively. In accordance with the Agreements, the Group has obtained exclusive commercialization rights for these two products in mainland China and exclusive licensing rights for the rest of the Asia-Pacific region, the Middle...
Eupraxia Pharmaceuticals Announces Pricing of US$70 Million Public Offering of Common Shares
Written by Customer Service on . Posted in Public Companies.
VICTORIA, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced the pricing of its previously announced public offering (the “Offering”) of 12,727,273 common shares of the Company (the “Common Shares”) at a price to the public of US$5.50 per Common Share for gross proceeds of approximately US$70 million, before deducting the underwriting commissions and estimated expenses incurred in connection with the Offering. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,909,090...
Big 5 Sporting Goods Corporation Postpones Special Meeting of Stockholders; Urges Stockholders to Continue Voting “For” the Merger and Related Proposals at the Special Meeting
Written by Customer Service on . Posted in Mergers And Acquisitions.
$1.45 per share all-cash consideration contemplated by the proposed merger with Worldwide Golf (the “Merger”) is the conclusion of an eight-month process with multiple parties that resulted in three proposals.
Postpones Special Meeting of Stockholders to September 26, 2025.
Your vote is very important, regardless of the number of shares that you own. The transaction cannot be completed unless the Merger proposal is approved by the holders of at least a majority of the issued and outstanding shares of Big 5 common stock.
Independent proxy advisory firms ISS and Glass Lewis both recently issued recommendations in favor of the Merger.
Previously submitted votes remain valid with no further action required.
If you have any questions about voting, please call Innisfree, our proxy solicitor, toll-free at (877) 687-1873 if in North America,...
Platinum Analytics Cayman Limited Announces Closing of Its Initial Public Offering and Full Exercise of Over Allotment
Written by Customer Service on . Posted in Public Companies.
Singapore, Sept. 22, 2025 (GLOBE NEWSWIRE) — Platinum Analytics Cayman Limited (the “Company” or “PLTS”), a software developer specializing in the provision of FX trading software development solutions, data analytics solutions and technology development solutions to financial institutions with a strategic focus on serving Asia and other emergent markets, today announced the closing of its initial public offering (the “Offering”) of 2,300,000 Class A ordinary shares (the “Ordinary Shares”), which included the underwriters’ full exercise of their over-allotment option, at a public offering price of $4.00 per share for gross proceeds of $9,200,000, before deducting underwriting discounts and offering expenses. The Offering closed on September 22, 2025 and the Ordinary Shares commenced trading on the Nasdaq Capital Market on September...
Minute Media Acquires VideoVerse, Owner of Magnifi, A Leading AI Sports Video Technology Platform
Written by Customer Service on . Posted in Mergers And Acquisitions.
The acquisition comes a year after a series of robust sports technology and content additions to Minute Media’s portfolio, culminating with a 360-degree solution for
rightsholders, leagues, teams, publishers, and marketers
NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) — Minute Media, a leading global technology and sports content company, today announced its acquisition of VideoVerse. VideoVerse’s leading product, Magnifi, an AI-driven SaaS technology platform, enables content owners and rights holders to automatically detect key moments, create highlights in real time, and distribute compelling short-form video content efficiently.
The addition of VideoVerse will enable Minute Media to provide unprecedented value to the sports content ecosystem, furthering both parties’ partnership capabilities. With this acquisition, Minute Media...
Microvast at BICES 2025: Electrifying Construction Machinery
Written by Customer Service on . Posted in Public Companies.
STAFFORD, Texas, Sept. 22, 2025 (GLOBE NEWSWIRE) — Microvast Holdings, Inc. (NASDAQ: MVST) (“Microvast”, the “Company” or “we”), a global leader in advanced battery technologies, will showcase its suite of high-performance battery products at the Beijing International Construction Machinery, Building Material Machines, and Mining Machines Exhibition & Symposium (BICES 2025). The event will be held at the China International Exhibition Center’s Shunyi Exhibition Hall September 23-26, 2025. At booth E 2170, Microvast will present efficient power solutions for applications including all-electric and hybrid mining trucks.
Addressing the high-intensity demands of construction machinery, Microvast will highlight its fast-charging battery solutions. Microvast’s HpTO-37Ah, MpCO-48Ah, and HpCO-55Ah battery models are engineered...
